# ZIKA Vaccine in Naive Subjects

> **NCT02952833** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 91 (actual)

## Conditions studied

- Zika Virus Infection

## Interventions

- **DRUG:** Saline
- **BIOLOGICAL:** Zika Virus Purified Inactivated Vaccine (ZPIV)

## Key facts

- **NCT ID:** NCT02952833
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-14
- **Primary completion:** 2018-12-05
- **Final completion:** 2018-12-05
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02952833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02952833, "ZIKA Vaccine in Naive Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02952833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*